Charles & Colvard, Ltd. (CTHR)
| Previous Close | 1.3700 |
| Open | 1.3450 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.2800 - 1.3900 |
| 52 Week Range | 1.1800 - 4.9000 |
| Volume | |
| Avg. Volume | 15,396 |
| Market Cap | 4.006M |
| Beta (5Y Monthly) | 1.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.0000 |
| Earnings Date | Nov 18, 2024 - Nov 22, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 29, 2007 |
| 1y Target Est | N/A |
GlobeNewswireMilestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support throu
PR NewswireCharles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today announced that on October 18, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the "Listing Rule"), as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended J
